FENNEC PHARMACEUTICALS INC. Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Fennec Pharmaceuticals Inc. quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Other Assets, Current for the quarter ending September 30, 2024 was $546K, a 2630% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $546K +$526K +2630% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $283K +$251K +784% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $161K +$129K +403% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $44K -$19K -30.2% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $20K -$103K -83.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $32K -$117K -78.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $32K -$122K -79.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $63K -$190K -75.1% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $123K -$289K -70.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $149K -$223K -59.9% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $154K -$301K -66.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $253K -$23K -8.33% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $412K +$408K +10200% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $372K +$368K +9200% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $455K +$453K +22650% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $276K +$268K +3350% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $4K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $4K +$3K +300% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2K -$2K -50% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $8K +$7K +700% Dec 31, 2019 10-K 2021-03-30
Q2 2019 $1K -$3K -75% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $4K -$6K -60% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $1K -$12K -92.3% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $0 -$2K -100% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $4K -$2K -33.3% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $10K +$5K +100% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $13K +$10K +333% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $2K $0 0% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $6K +$1K +20% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $5K +$2K +66.7% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $3K +$2K +200% Dec 31, 2016 10-K 2018-03-28
Q3 2016 $2K +$1K +100% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $5K +$2K +66.7% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $3K +$1K +50% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $1K -$16K -94.1% Dec 31, 2015 10-K 2017-03-29
Q3 2015 $1K -$12K -92.3% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $3K -$6K -66.7% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $2K -$1K -33.3% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $17K +$9K +113% Dec 31, 2014 10-K 2016-03-28
Q3 2014 $13K +$12K +1200% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $9K +$6K +200% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $3K $0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $8K +$2K +33.3% Dec 31, 2013 10-K 2015-03-31
Q3 2013 $1K -$5K -83.3% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 $3K $0 0% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $3K -$11K -78.6% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 $6K -$13K -68.4% Dec 31, 2012 10-K 2014-03-31
Q3 2012 $6K -$9K -60% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $3K -$5K -62.5% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $14K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $19K +$11K +138% Dec 31, 2011 10-K 2013-04-01
Q3 2011 $15K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $8K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $8K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.